Controversy Brews Over Xigris’ Role in Treating Sepsis
Laurie Barclay, MD Oct. 1, 2002 Sounding board articles in the Sept. 26 issue of the
Laurie Barclay, MD Oct. 1, 2002 Sounding board articles in the Sept. 26 issue of the
Patients on warfarin appear to have a significantly higher incidence of embolic events than heart failure patients
By Martha Kerr NEW YORK (Reuters Health) Sept 26 – Boston researchers report that through the use
Laurie Barclay, MD Sept. 27, 2002 Compared with stents, coronary artery bypass graft (CABG) reduced the
Laurie Barclay, MD Sept. 27, 2002 Two studies presented on Sept. 26 at the American Heart
Immune modulation therapy (IMT) appears to reduce death and hospitalization among patients with chronic heart failure. Dr.
Carvedilol, alone or in combination with standard heart failure therapy, appears to reverse chemotherapy-induced congestive heart failure.
Atorvastatin 80 mg/day lowered low-density lipoprotein (LDL) cholesterol levels further than did pravastatin 40 mg/day, and it
In a multicenter randomized trial reported in the Sept. 26 issue of the New England Journal of
Diabetic patients with chronic heart failure who were taking thiazolidinediones (TZD) developed refractory fluid retention, resulting in
נא ציין כתובת דואר אלקטרוני שבה אתה מקבל דיוורי e-Med או זו שציינת בכרטיס האישי שלך.
קישור לאיפוס סיסמא נשלח למייל.
חזרה להתחברות